Julian Levell

Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT)

Alexandra Grassian, Fallon Lin, Rosemary Barrett et al. · Journal of Biological Chemistry · 2012 · 136 citations · Full text

Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor

Young Shin Cho, Julian Levell, Gang Liu et al. · ACS Medicinal Chemistry Letters · 2017 · 113 citations · Full text

New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factor‐like repeat A docking site using WaterMap

Robert A. Pearlstein, Qiying Hu, Jing Zhou et al. · Proteins Structure Function and Bioinformatics · 2010 · 78 citations

Proteomic Technology, Proteinlipid Interaction, Protein Function +15

Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor

Jonathan E. Wilson, Gaurav Patel, Chirag Patel et al. · ACS Medicinal Chemistry Letters · 2020 · 74 citations · Full text

Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity

Xiaoling Xie, Daniel Baird, Kimberly Elizabeth Bowen et al. · Structure · 2017 · 66 citations

Molecular Pharmacology, Biochemistry, Natural Sciences +7